Skip to main content

Table 1 Clinical characteristics of the LUAD patients

From: TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma

Characteristic

Levels

Overall

n

 

535

Age, n (%)

≤65

255 (49.4%)

> 65

261 (50.6%)

Gender, n (%)

Female

286 (53.5%)

Male

249 (46.5%)

T stage, n (%)

T1

175 (32.9%)

T2

289 (54.3%)

T3

49 (9.2%)

T4

19 (3.6%)

N stage, n (%)

N0

348 (67.1%)

N1

95 (18.3%)

N2

74 (14.3%)

N3

2 (0.4%)

M stage, n (%)

M0

361 (93.5%)

M1

25 (6.5%)

Pathologic stage, n (%)

Stage I

294 (55.8%)

Stage II

123 (23.3%)

Stage III

84 (15.9%)

Stage IV

26 (4.9%)

Smoker, n (%)

No

75 (14.4%)

Yes

446 (85.6%)